InSite Vision Inc. (fka INSV)

[mlkrborn]

Insite Vision receives broad patent approval in Japan (INSV) 0.45 : Co announced that the Japanese Patent Office has issued a Notice to Patent with claims covering the formulation of azithromycin alone or combined with an anti-inflammatory agent, including dexamethasone, in an aqueous topical opththalmic suspension. The patent will expire on March 31, 2019. Japan is the third largest ophthalmic market in the world after the United States and the European Union.